Tezepelumab Effective in Severe Asthma Cohorts Stratified by Age at Onset, Inflammatory Phenotype, and Allergen Sensitization
AAAAI 2023. The TSLP inhibitor was superior to placebo in 2 post hoc analyses of the PATHWAY and NAVIGATOR clinical trials.
AAAAI 2023: Pediatric Asthma Risk Score Validated in Multi-cohort Study
Future studies may consider PARS the new gold standard in predicting pediatric asthma risk, said study authors.
For Persons with Asthma Infected with COVID-19, Systemic Corticosteroid Prescribing is Up
AAAAI 2023. Pandemic prescribing rates for systemic corticosteroids increased from Alpha to Delta to Omicron waves of COVID-19 but hospitalizations have dropped, study finds.
AAAAI 2021: Asthma Not an Independent Predictor of Severe COVID-19 Outcomes
Recent research presented at AAAAI 2021 Virtual Annual Meeting suggests asthma is not an independent risk factor for severe COVID-19 or hospitalization.
Significant Reductions in Exacerbations Seen in Broad Population of Severe Asthma Patients
Statistically significant reductions in annual exacerbation rates were seen across baseline eosinophil and exhaled FeNO level and allergy status with telepezumab, in the phase 3 NAVIGATOR trial.
Expert-guided Online Decision Tool Supports Real-time Treatment Choice for Severe Asthma
Treatment for severe asthma may be enhanced using an online decision support tool that draws on expert treatment decisions for a wide variety of potential patient scenarios.
Asthma Patients with COVID-19 at Comparable Risk of Hospitalization
Patients with COVID-19 who have asthma share a similar risk of hospitalization with patients with the infection who do not have asthma, according to new research.
Use of Face Masks Does Not Affect Oxygen Saturation in Asthma Patients
AAAAI Virtual Annual Meeting. Among patients with asthma, wearing a mask, regardless of type or duration of use, had no significant effect on oxygen saturation.
AAAAI 2021 Virtual Annual Meeting: A First Look
Get a first look at key 8 studies to be presented at the upcoming AAAAI 2021 virtual meeting starting this Friday, February 26, 2021.
Biologic Eliminates or Reduces Oral Steroids in Severe Asthma: PONENTE Trial
AAAAI Virtual Annual Meeting. Two-thirds of severe asthma patients dependent upon oral corticosteroids stopped or maximally reduced use, according to the trial data.